NCT00393354已完成3 期
A Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Trial to Assess the Efficacy and Safety of MK0663 in Patients With Chronic Low Back Pain
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 325
- 主要终点
- Low back pain intensity scale (0-100 mm VAS) over 4 weeks compared to placebo
研究概览
简要总结
Study the effect of etoricoxib 60 mg and 90 mg compared to placebo to treat chronic low back pain.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Low back pain for previous 3 months and majority of days in last month
- •Regular use of acetaminophen or NSAID to treat low back pain in past month
- •Judged to be in otherwise good health
排除标准
- •Low back pain that is due to secondary causes
- •Radicular/myelopathic pain
- •Surgery for low back pain within the past 6 months
- •Active lawsuit or claim pertaining to their low back pain
- •Disease that may confound the results of the study or pose risk to the patients
- •Corticosteroid use in past month
- •Previous participation in MK0663 study
结局指标
主要结局
Low back pain intensity scale (0-100 mm VAS) over 4 weeks compared to placebo
次要结局
- Low back pain intensity scale (0-100 mm VAS) over 12 weeks compared to placebo
研究者
相似试验
已完成
3 期
Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)Recurrent Low Back PainNCT00393211Organon and Co319
已完成
3 期
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)Acute Pain Following a Total Abdominal HysterectomyNCT00788710Organon and Co430
已完成
2 期
Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)OsteoarthritisNCT00242489Organon and Co1,167
撤回
4 期
A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)OsteoarthritisNCT01429168Organon and Co
已完成
1 期
Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric ExerciseMuscle PainNCT01271348X-pert Med GmbH50